New patent for Optinose Us drug XHANCE

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for XHANCE
Annual Drug Patent Expirations for XHANCE

Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. It is available from one supplier. There are thirteen patents protecting this drug.

XHANCE drug price trends.

This drug has two hundred and fifty-three patent family members in twenty-nine countries.

The generic ingredient in XHANCE is fluticasone propionate. One supplier is listed for this compound. Additional details are available on the fluticasone propionate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top